Annual Drug Patent Expirations for EPHEDRINE+SULFATE
Ephedrine Sulfate is a drug marketed by Amneal, Dr Reddys, Endo Operations, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Mankind Pharma, Renew Pharms, Sagent Pharms Inc, Sandoz, Xiromed, and Zydus Pharms and, and is included in thirteen NDAs. It is available from sixteen suppliers. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in EPHEDRINE SULFATE is ephedrine sulfate. Sixteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the ephedrine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com